1. Trang chủ
  2. » Tất cả

(6) (Traditional Herbal Medicines for Modern Times) Amala Soumyanath - Traditional Medicines for Modern Times_ Antidiabetic Plants-CRC Press Taylor&Francis (2005)

331 48 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Cấu trúc

  • Cover

  • Title

  • Publisher

  • Dedication

  • Preface

  • Acknowledgments

  • Editor

  • Contributors

  • Table of Contents

  • Chapter 1 Introduction to Diabetes Mellitus

    • What is Diabetes?

    • Physiological Actions of Insulin

      • Insulin Action on Glucose Metabolism

      • Insulin Action on Fat Metabolism

      • Insulin Action on Protein Metabolism

    • Physiological Actions of Glucagon

    • Molecular Mechanisms of Insulin Action

    • Classification of Diabetes

    • Disease Mechanisms in Diabetes

      • Type 1 Diabetes

      • Type 2 Diabetes

    • Clinical Presentation of Diabetes

      • Type 1 Diabetes

      • Type 2 Diabetes

    • Long-Term Complications of Diabetes

    • Global Burden of Diabetes and Ethnicity

    • Diabetes Treatment Options

      • Delay Gastric Emptying

      • Reduce Absorption of Carbohydrate

      • Increase Pancreatic Insulin Secretion

        • Insulin Replacement

        • Insulinomimetic Agents

      • Reduce Hepatic Glucose Output

      • Increase Insulin Sensitivity

      • Weight Loss and Exercise

      • Alter Renal Glucose Handling

    • Unmet Needs

    • References

  • Chapter 2 Plants Used in the Treatmentof Diabetes

    • Background

    • Selection of Species

    • Where Do We Go Next?

    • Acknowledgments

    • References

  • Chapter 3 Preclinical and Clinical Methods for Evaluating Antidiabetic Activity of Plants

    • Introduction

    • Animal Models

    • Insulin-Dependent Models

      • Spontaneous and Transgenic Models

      • Experimentally Induced Models

    • Non-Insulin-Dependent Models

      • Spontaneous and Transgenic Models

      • Experimentally Induced Models

    • Models of Diabetic Complications

      • Selecting an Appropriate Model to Test Plant Materials

    • Tests for Antidiabetic Activity

    • Clinical Evaluation of Antidiabetic Plants

      • Phase 1 Trial Designs

      • Phase 2 Trial Designs

      • Phase 3 Trial Designs

    • Ethical Issues

    • Conclusion

    • References

  • Chapter 4 In Vitro Models for Assessing Antidiabetic Activity

    • Introduction

    • Rationale Behind the in Vitro Models Used in Diabetes Research

    • Models to Study Inhibition of Carbohydrate-Digesting Enzymes

    • Models to Study Inhibition of Intestinal Glucose Uptake

    • Models to Study Insulin Secretion from β-Cells of the Pancreas

    • Models Based on the Liver as an Insulin Target Tissue

    • Models Based on Adipocytes as an Insulin Target Tissue

    • Models Based on Muscle as an Insulin Target Tissue

    • Interactions with the Insulin Receptor

    • Glucagon Receptor Antagonists

    • Practical Considerations

      • Potential Interferents in Plant Extracts

      • Solubilizing Plant Extracts for In Vitro Studies

      • An Alternative Glucose Substrate for In Vitro Uptake Studies

    • Conclusion

    • References

  • Chapter 5 Ayurvedic, Siddha, and Tribal Medicine

    • Introduction

    • Syzigium cumini Linn. (Jamun)

      • Phytochemistry

    • Tinospora cordifolia Miers

      • Phytochemistry

    • Trigonella foenum graecum Linn. (Fenugreek)

      • Phytochemistry

    • Momordica charantia Linn

      • Phytochemistry

    • Gymnema sylvestre R. Br.

      • Phytochemistry

    • Pterocarpus marsupium Roxb.

      • Phytochemistry

    • Conclusion

    • References

  • Chapter 6 Traditional Chinese and Kampo Medicines

    • Introduction

    • Kampo Medicines with Antidiabetic Effects

      • Bakumondo-to (Mai-men-dong-tang)

      • Bofu-tsusho-san (Fang-feng-tong-sheng-san)

      • Byakko-ka-ninjin-to (Bai-hu-jia-ren-sheng-tang)

      • Dai-sakiko-to (Dai-chai-hu-tang)

      • Gosha-jinki-gan (Niu-che-shen-qi-wan)

      • Hatimi-jio-gan (Bai-wei-di-huang-wan)

      • Hochu-ekki-to (Bu-zhong-yi-qi-tang)

      • Keishi-bukuryo-gan (Gui-zhi-fu-ling-wan)

      • Rokumi-gan (Liu-wei-wan)

      • Saiko-keishi-kankyo-to (Chai-hu-gui-zhi-gan-jian-tang)

    • Herbs with Hypoglycemic Effects

      • Anemarrhenae Rhizoma (Anemarrhena Rhizome)

      • Araliae Cortex (Aralia Bark)

      • Corni Fructus (Cornus Fruit)

      • Dioscoreae Rhizoma (Dioscorea Rhizome)

      • Ginseng Radix (Ginseng)

      • Mori Folium (Mulberry Leaf)

      • Ophiopogonis Tuber (Ophiopogon Tuber)

      • Paeoniae Radix (Peony Root)

      • Platycodi Radix (Platycodon Root)

      • Polygonati Rhizoma (Polygonatum Rhizome)

      • Poria (Hoelen)

      • Rehmanniae Radix (Rehmannia Root)

      • Swertiae Herba (Swertia Herb)

      • Others

    • Herbs with Inhibitory Activity against Aldose Reductase

      • Glycyrrhizae Radix (Glycyrrhiza)

    • References

  • Chapter 7 Treating Non-Insulin-Dependent Diabetes Mellitus from a Western Herbalist’s Perspective

    • Introduction

    • Traditional Western Antidiabetic Herbs

      • Bitters

        • Barberry Root Bark (Berberis vulgaris L.; Berberidaceae)

        • Milk Thistle (Silybum marianum Gaertn; Asteraceae/Compositae)

        • Bilberry Leaf and Fruit (Vaccinium myrtillus L.; Vacciniaceae)

        • Aloe Vera (Aloe vera L.; Liliaceae)

        • Juniper (Juniperus communis L.; Coniferae)

        • Goat’s Rue (Galega officinalis L.; Leguminosae/Fabaceae)

    • Treatment of Diabetes by the Modern Western Herbalist

      • Gymnema (Gymnema sylvestre R. Br.; Asclepiadaceae)

      • Fenugreek Seeds (Trigonella foenum-graecum L.; Leguminosae/Fabaceae)

      • Suma (Pfaffia paniculata (Mart.) Kuntze; Amaranthaceae)

      • American Ginseng (Panax quinquefolium L.; Araliaceae)

      • Prickly Pear (Opuntia spp.; Cactaceae)

      • Devil’s Club (Oplopanax horridum (Sm.) Torr. & A. Gray ex. Miq.; Araliaceae)

      • Queen’s Crepe Myrtle (Lagerstroemia speciosa L.; Lythraceae)

    • Herbs for Use in Adjunct Therapies

      • Bilberry Fruit (Vaccinium myrtillus L.; Vacciniaceae)

      • Ginkgo Biloba (Ginkgo biloba L.; Ginkgoaceae)

      • Cayenne (Capsicum spp.; Solanaceae)

    • Nutritional Therapies and Exercise

      • Diet

      • Exercise

    • Conclusion

    • References

  • Chapter 8 Native American Medicine

    • Introduction

    • Rise in Prevalence of Type 2 Diabetes among Native Americans:

    • Historic Evidence and Modern Trends

    • Plants Used for the Treatment of Diabetes in North America

    • Conclusions

    • References

  • Chapter 9 Antidiabetic Plants in Mexico and Central America

    • Introduction

    • Methods

    • Results

    • Discussion

    • Conclusion

    • References

  • Chapter 10 Antidiabetic Plants in the Caribbean

    • Introduction

    • Dietary Aspects

    • The Herbal Remedies

    • Future Directions

    • References

  • Chapter 11 Management of Diabetes in African Traditional Medicine

    • Introduction

    • Dietary Approaches

    • Ethnomedicinal Approaches

      • Acanthaceae Family

      • Anarcadiaceae Family

      • Apocynaceae Family

      • Asteraceae Family

      • Bignoniaceae Family

      • Combretaceae Family

      • Cruciferae Family

      • Cucurbitaceae Family

      • Ebenaceae Family

      • Euphorbiaceae Family

      • Fabaceae Family

      • Liliaceae Family sensu lato

      • Menispermaceae Family

      • Moraceae Family

      • Musaceae Family

      • Myrtaceae Family

      • Oxalidaceae Family

      • Tiliaceae Family

      • Miscellaneous Families

    • Conclusion

    • References

  • Chapter 12 Antidiabetic Plants of North Africa and the Middle East

    • Introduction

    • Allium cepa and Allium sativum (Liliaceae Family)

    • Aloe vera (Liliaceae Family)

    • Artemisia herba-alba (Compositae Family)

    • Atriplex halimus (Chenopodiaceae Family)

    • Lupinus albus (Leguminosae Family)

    • Momordica charantia (Cucurbitaceae Family)

    • Nigella sativa (Ranunculaceae Family)

    • Olea europea (Oleaceae Family)

    • Poterium spinosum (Rosaceae Family)

    • Rhazya stricta (Apocynaceae Family)

    • Trigonella foenum graecum (Leguminosae Family)

    • Zygophyllum gaetulum (Zygophylaceae Family)

    • Conclusion and Perspectives

    • References

  • Chapter 13 Australian and New Zealand Plants with Antidiabetic Properties

    • Introduction

    • Indigenous People

      • Australia

      • New Zealand

    • Aboriginal Health

      • Attitude to Illness

      • Diabetes

    • Australian Plants with Hypoglycemic Properties

      • Acacia Species (Mimosaceae)

      • Eucalyptus Species (Myrtaceae)

      • Eremophila Species (Myoporaceae)

    • Other Plants Useful in Treatment of Diabetes

    • Plants Related to Species with Known Hypoglycemic Properties

      • Australian

      • New Zealand

    • Concluding Remarks

    • References

  • Chapter 14 Plant Polysaccharides in the Prevention and Treatment of Diabetes Mellitus

    • Introduction

    • Definition of Polysaccharides

    • The Role of Starch

    • Factors Affecting Glycemic Response to Foods

      • The Glycemic Index and Diabetes

      • The Role of Water-Soluble NSP

      • Mechanisms of Action of Viscous Polysaccharides

    • New Sources of Plant Polysaccharides

    • Conclusions

    • References

  • Chapter 15 Saponins

    • Steroidal Saponins with Hypoglycemic Effects in Diabetic Animals

    • Triterpene Saponins with Hypoglycemic Effects in Diabetic Animals

    • Triterpene Saponins with Accelerating Effects on Glucose Transport In Vitro

    • Triterpene Saponins with Antihyperglycemic Effects in Sugar-Loaded Animals

      • Olean-12-en-28-oic Acid 3-Monodesmosides

      • Acylated Polyhydroxyolean-12-ene 3-Monodesmoside

        • Escins

        • Gymnema Saponins

        • Tea Saponins

      • Olean-12-ene 3,28-Acylated Bisdesmoside

        • Senega Saponins

    • Mode of Action of Triterpene Saponins on the Antihyperglycemic Effect in Glucose-Loaded Rats

    • Inhibitory Effects of Oleanolic Acid Glycosides on GE in Mice

    • References

  • Chapter 16 Flavonoids, Xanthones, and Other Antioxidant Polyphenols

    • Diabetes and Oxidative Stress

    • Role in Diabetic Complications

      • Tumor Necrosis Factor-α

      • Endothelial Dysfunction: Diabetic Macro- and Microvascular Complications

    • Antioxidants and Diabetes

      • General Antioxidants

        • Antioxidants in Models of Diabetes

        • Glucose-Lowering Effects of Flavonoids and Xanthones

        • Protectors and Enhancers of Endogenous Defense

        • Inhibition of Advanced Glycation Endproducts (AGEs)

        • Aldose Reductase Inhibitors

        • Inhibition of LDL Peroxidation and Hypolipidemic Effects

      • Implications for Therapies and Diets

        • Methodological Considerations

        • Patterns of Traditional and Contemporary Plant Use

      • Conclusion

      • References

  • Index

Nội dung

Traditional Herbal Medicines for Modern Times Traditional Medicines for Modern Times Antidiabetic Plants Traditional Herbal Medicines for Modern Times Each volume in this series provides academia, health sciences and the herbal medicines industry with in-depth coverage of the herbal remedies for infectious diseases, certain medical conditions, or the plant medicines of a particular country Edited by Dr Roland Hardman Volume Shengmai San, edited by Kam-Ming Ko Volume Rasayana: Ayurvedic Herbs for Rejuvenation and Longevity,  by H.S Puri Volume Sho-Saiko-To: (Xiao-Chai-Hu-Tang) Scientific Evaluation and Clinical  Applications, by Yukio Ogihara and Masaki Aburada Volume Traditional Medicinal Plants and Malaria, edited by Merlin Willcox,  Gerard Bodeker, and Philippe Rasoanaivo Volume Juzen-taiho-to (Shi-Quan-Da-Bu-Tang): Scientific Evaluation and  Clinical Applications, edited by Haruki Yamada and Ikuo Saiki Volume Traditional Medicines for Modern Times: Antidiabetic Plants,  edited by Amala Soumyanath Traditional Herbal Medicines for Modern Times Traditional Medicines for Modern Times Antidiabetic Plants Edited by Amala Soumyanath Boca Raton London New York A CRC title, part of the Taylor & Francis imprint, a member of the Taylor & Francis Group, the academic division of T&F Informa plc Published in 2006 by CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2006 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group No claim to original U.S Government works Printed in the United States of America on acid-free paper 10 International Standard Book Number-10: 0-415-33464-0 (Softcover) International Standard Book Number-13: 978-0-415-33464-8 (Softcover) Library of Congress Card Number 2005049792 This book contains information obtained from authentic and highly regarded sources Reprinted material is quoted with permission, and sources are indicated A wide variety of references are listed Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use No part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc (CCC) 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400 CCC is a not-for-profit organization that provides licenses and registration for a variety of users For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe Library of Congress Cataloging-in-Publication Data Traditional medicines for modern times : antidiabetic plants / edited by Amala Soumyanath p cm – (Traditional herbal medicines for modern times ; v 6) Includes bibliographical references and index ISBN 0-415-33464-0 (alk paper) Diabetes Herbs – Therapeutic use Traditional medicine Materia medica, Vegetable Pharmacognosy I Soumyanath, Amala II Series RC661.H4T73 2005 616.4'62061 – dc22 2005049792 Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com Taylor & Francis Group is the Academic Division of T&F Informa plc and the CRC Press Web site at http://www.crcpress.com Dedication To our parents and forebears for their guidance and wisdom Preface Diabetes mellitus (diabetes) is a disease of worldwide significance and increasing prevalence Plant materials have played an important role in the traditional treatment of diabetes, particularly the type II (non-insulin-dependent) form In many regions of the world, herbal remedies continue to be more accessible and affordable than conventional drugs and represent the first line of treatment available to a diabetes patient Concurrently, within societies with well-developed, modern health care systems, demand is growing for herbal remedies to complement prescribed, modern therapies for many diseases, including diabetes This volume is the first detailed compilation of information from across the world on plants used traditionally to treat diabetes and the scientific methods by which they can be and have been investigated The book is divided into three main themes It begins with an introduction to diabetes mellitus by a consultant physician and a major updated review and discussion of scientific information pertaining to traditional antidiabetic plants compiled by authors from the Royal Botanic Gardens, Kew, London For those interested in performing research in this field, the next chapters provide an outline of clinical, in vivo, and in vitro methods for assessing antidiabetic activity of plant materials Then follows a set of chapters by an international group of authors that describe traditional plant remedies used in Asia, the Americas, Africa, Europe, and Australia The final chapters emphasize the role of particular phytochemical groups in the treatment of diabetes The potential role of plants in treating or preventing the complications of diabetes, is mentioned in the chapters on Chinese and Kampo medicines, a Western herbalist’s perspective, and flavonoids, xanthones, and other antioxidant polyphenols This latter chapter and that on plant polysaccharides highlight the important role of dietary plant materials in the prevention and control of diabetes Indeed, it is believed that changes in diet from traditional plant foodstuffs containing beneficial components to richer, more processed and “junk” food is responsible for the increasing prevalence of diabetes worldwide A number of important points emerge from this volume It is apparent that diversity as well as similarity can be found in the use of plants across the world Understandably, each region of the world has developed a materia medica of antidiabetic remedies based on the local flora However, the use of certain plants such as Momordica charantia L (bitter melon) and Trigonella foenumgraecum L (fenugreek) appears in more than one region Climatic factors and cross-cultural communication play a role here Generally, the use of a particular plant in a number of regions is strong evidence for its effectiveness Diversity is also seen in the range of plant families and types of phytochemicals associated with antidiabetic activity At the same time, certain groups, such as alkaloids, saponins, xanthones and flavonoids, and nonstarch polysaccharides appear to have effects of particular significance in diabetes treatment The extent to which various antidiabetic plants have been studied differs widely For some (e.g., fenugreek, bitter melon, or gymnema [Gymnema sylvestre R Br.]), detailed studies in humans, animals, and in vitro have resulted in the isolation of active compounds with recognizable modes of action An interesting finding is that plants typically have more than one active component, often associated with more than one mode of action Additive or synergistic effects between components undoubtedly occur, conforming to the view of traditional herbalists that the activity of a medicinal plant cannot be reproduced by the isolation of a single active component Nevertheless, identification of actives and modes of action are important for drug development, and for the validation, standardization, and rational use of traditional herbal remedies To what extent has knowledge of traditional antidiabetic plants influenced the development of new antidiabetic drugs? Apart from the conventional drug metformin, which is based on the structure of galegine (a component of the European antidiabetic herb Galega officinalis L.), no new antidiabetic drugs derived from higher plants have been introduced into the market This is rather surprising, given the large number of antidiabetic plants available and the wealth of documented information about them One factor may be that research in the pharmaceutical industry has lately been heavily based on high-throughput in vitro screening programs The capacity of these systems to handle large numbers of samples has led to random screening rather than selection from ethnobotanical materials Complex extracts of natural products are, understandably, less attractive to the industry than screening single compounds from synthetic libraries because a “hit” would need to be followed up by isolation and identification of the active compound within the extract Legal access to plant material from other countries and conservation issues as covered by the Convention on Biodiversity and other international agreements are additional limiting factors As a result, natural products derived from microbial sources have featured much more extensively in screening programs than have higher plants, let alone traditional plant remedies A final factor is that high-throughput assays tend to be highly focused in their target mechanism and that, although effective in diabetes, the plant material may not work in that particular way An alternate, more successful approach (pioneered by a smaller company) was to test ethnobotanically selected plants in vivo in experimental diabetic animals for initial determination of activity This was followed by in vivo and in vitro testing to guide further fractionation This approach has led to the identification of a number of active compounds as candidates for drug development New investigational drugs must pass many hurdles relating to efficacy and toxicity issues before they are approved for use in the clinic; this, too, is a confounding factor in the introduction of new antidiabetic drugs from plant sources Much research on antidiabetic plants has been undertaken in academia Indeed, the majority of the data described in this volume on activity and active components of these plants is from this source This situation is likely to continue and, hopefully, increase in response to the growing prevalence of diabetes worldwide Academia has traditionally been more inclined to follow ethnobotanical leads, but much of the early research led to publications rather than patents A greater awareness of intellectual property issues coupled with greater synergy with the pharmaceutical industry may well lead to the development of new drugs from this route If not conventional drugs — what about herbal remedies for diabetes? Plant remedies have been and are being used by diabetic patients throughout the world Research suggests that using an antidiabetic plant in whole form or as complex extracts may offer many benefits due to the presence of multiple active components Of considerable benefit would be well researched herbal products based on traditional preparation methods and standardized to contain effective levels of the most important components for activity Given the limited resources of most of the companies producing herbal products, research into these agents is, again, most likely to take place in an academic setting or by government-sponsored agencies as in many developing countries It is also necessary for medicine’s regulatory authorities to develop special criteria for the evaluation and licensing of herbal antidiabetic products Finally, patients and health care providers need to be educated in the use of these products as sole or complementary treatments for diabetes in order to ensure their safe and effective use It is the hope of the editor that this volume will be of value to all those with an interest in antidiabetic plants and that it will facilitate the application of traditional knowledge to treatment of diabetes in modern and future times All the authors who contributed to this volume are very gratefully acknowledged Acknowledgments I sincerely thank all the authors of this volume for their enthusiasm, their valuable contributions, and their patience with the editor during the long process of bringing this book to fruition I express here my deep appreciation of my husband, K Soumyanath, and my mother, Parvathi Raman Their affection, encouragement, and practical support at a demanding time made it possible to undertake and complete this project ... Saiki Volume Traditional Medicines for Modern Times: Antidiabetic Plants,  edited by Amala Soumyanath Traditional Herbal Medicines for Modern Times Traditional Medicines for Modern Times Antidiabetic. . .Traditional Herbal Medicines for Modern Times Traditional Medicines for Modern Times Antidiabetic Plants Traditional Herbal Medicines for Modern Times Each volume in... Amala Soumyanath p cm – (Traditional herbal medicines for modern times ; v 6) Includes bibliographical references and index ISBN 0-4 1 5-3 346 4-0 (alk paper) Diabetes Herbs – Therapeutic use Traditional

Ngày đăng: 16/12/2020, 10:55

TỪ KHÓA LIÊN QUAN